Overview

Heparin vs Placebo for Cardiac Catheterization

Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.
Phase:
Phase 3
Details
Lead Sponsor:
Lawson Health Research Institute
Treatments:
Heparin